Its most significant highlight is its ability to overcome the binding protein barrier in the body. Ordinary natural IGF-1 is largely bound and sealed by IGFBP protein upon entering the body, resulting in extremely low utilization. This product, through amino acid site modification, exhibits a drastic decrease in its binding ability to binding proteins, significantly increasing the proportion of free active ingredients. At the same dosage, its efficacy far surpasses that of the original IGF-1.
Its long-lasting effect greatly reduces the frequency of use. Native IGF-1 has a rapid metabolism and a half-life of only a few minutes, requiring frequent, intermittent replenishment. The LR3-modified version maintains its effect for over twenty hours in the half-cycle, providing long-lasting sustained release. Whether in cell culture or in vitro experiments, repeated additions of material are unnecessary, saving consumables and time.
It exhibits stronger tolerance to environmental fluctuations. Short-term storage at room temperature and short-term storage after solution preparation results in significantly lower activity loss than ordinary IGF-1. It also demonstrates excellent stability during aliquot storage, with small-batch aliquot storage minimizing inactivation, and has less stringent requirements for storage and handling environments.
Its long-lasting effect significantly reduces the need for repeated additions of material in cell culture and in vitro experiments, saving on consumables and labor time. The target effect is clearly defined, primarily targeting cell proliferation, soft tissue repair, and metabolic regulation. It has a specific target, fewer irrelevant side effects, stable experimental data reproducibility, and small batch-to-batch error.
The molecule is artificially modified with amino acids and does not belong to the naturally occurring homologous structure in the human body. Long-term, continuous use at high doses can easily interfere with the body's own endogenous IGF-1 secretion, leading to endogenous secretion inhibition. It should not be used indiscriminately for extended periods.
Compared to ordinary IGF-1 raw materials, the production cost is higher, resulting in a higher final purchase price. Large-scale industrial cultivation will increase the overall investment cost.
The onset of action is relatively slow, and its rapid effect is not as good as the short-acting original IGF-1. For scenarios requiring rapid proliferation in a short time, its compatibility is not as good as the short-acting version.
Compatibility is limited. Mixing it with some hormone reagents can easily lead to antagonistic activity. Random mixing will weaken the effects of both.
Research & Cell Experiments
Serious-free cell domestication and culture, stem cell expansion and cultivation, tumor cell mechanism research, and pharmacological experiments related to soft tissue cell repair are commonly used alternative raw materials in laboratories.
Animal Experiments
Small animal growth model construction, muscle tissue repair modeling, metabolic-related animal pharmacological evaluation, and developmental physiology research.
Commercial Use
Biomedical intermediate raw materials and in vitro tissue engineering research raw materials are for research purposes only and are not intended for human pharmaceutical finished products.
Storage Details
Unopened dry powder should be stored at -20℃ in a light-proof, sealed container, avoiding repeated freeze-thaw cycles. Dispense into small cryovials for each use, using one vial at a time. Do not refreeze any remaining stock solution.
Diluted aqueous solutions experience accelerated activity decay. After preparation, short-term refrigeration (2~8℃) is only suitable for 3~5 days. Long-term storage requires dispensing and freezing.
Keep away from humid and high-temperature environments. Moisture and clumping will directly damage the peptide chain structure, rendering the entire bottle unusable.
Do not arbitrarily increase the dosage or administer continuously without interruption. Follow the gradient dosage for trial use, and discontinue use periodically to allow endogenous hormones a recovery period.
Use sterile acetic acid solution or the matching buffer solution as the preferred solvent. Direct dissolution with pure water may easily cause protein denaturation and inactivation.
Use with caution in in vivo experiments during pregnancy and developmental stages, as it may disrupt the normal growth hormone rhythm of the individual and interfere with natural development.
This product is for in vitro experimental and animal research use only. Direct injection or oral administration to humans is strictly prohibited.
Hot Tags: bestselling model igf1-lr3, China bestselling model igf1-lr3 manufacturers, suppliers, factory
